Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-11-27 3:31 pm Unchanged | 13G | MyoKardia Inc. MYOK | INTEGRATED CORE STRATEGIES (US) LLC | 0 0.000% | 0 (Unchanged) | View |
2020-11-10 3:09 pm Sale | 13G | MyoKardia Inc. MYOK | PRICE T ROWE ASSOCIATES INC | 1,060,153 1.900% | -4,460,215 (-80.80%) | View |
2020-11-10 10:27 am Sale | 13G | MyoKardia Inc. MYOK | FMR LLC | 16,865 0.031% | -6,917,022 (-99.76%) | View |
2020-11-10 09:02 am Sale | 13G | MyoKardia Inc. MYOK | WELLINGTON MANAGEMENT GROUP LLP | 54,119 0.100% | -3,436,365 (-98.45%) | View |
2020-09-10 3:57 pm Purchase | 13G | MyoKardia Inc. MYOK | PRICE T ROWE ASSOCIATES INC | 5,520,368 10.400% | 1,941,660 (+54.26%) | View |
2020-02-14 1:30 pm Purchase | 13G | MyoKardia Inc. MYOK | PRICE T ROWE ASSOCIATES INC | 3,578,708 7.700% | 1,096,276 (+44.16%) | View |
2020-02-12 09:16 am Purchase | 13G | MyoKardia Inc. MYOK | VANGUARD GROUP INC | 3,951,583 8.540% | 888,701 (+29.02%) | View |
2020-02-07 11:24 am Purchase | 13G | MyoKardia Inc. MYOK | FMR LLC | 6,933,887 14.999% | 893,281 (+14.79%) | View |
2020-02-05 12:15 pm Purchase | 13G | MyoKardia Inc. MYOK | BlackRock Inc. BLK | 4,142,810 9.000% | 1,281,222 (+44.77%) | View |
2020-01-27 2:03 pm Purchase | 13G | MyoKardia Inc. MYOK | WELLINGTON MANAGEMENT GROUP LLP | 3,490,484 7.550% | 741,419 (+26.97%) | View |